+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07899502

REAL-MS Observational Study Comparing Stem Cell Transplantation and High-Efficacy Therapies in Adults with Multiple Sclerosis

Led by Imperial College London · Updated on 2026-10-27

2000

Participants Needed

3

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Multiple sclerosis MS is a disease where the immune system harms the brain and spinal cord. Treatments called disease-modifying therapies can help reduce inflammation and disease activity. For some adults with highly active MS, autologous haematopoietic stem cell transplantation AHSCT, which uses a persons own blood-forming stem cells after immune-suppressing treatment, may be an option. Researchers are comparing the long-term safety and effectiveness of AHSCT against high-efficacy disease-modifying therapies H-DMTs such as alemtuzumab, cladribine, natalizumab, and anti-CD20 antibody treatments in this observational study. The study collects information from routine clinical care without assigning or administering treatments. It includes adults with MS treated with either AHSCT or eligible H-DMTs during regular care. The research involves both retrospective data from patients treated between 2008 and 2025 and a prospective phase starting in October 2026 to gather ongoing clinical data. Data include demographics, treatment and relapse history, disability assessments, MRI findings, laboratory results, and safety events, all collected through standardized electronic forms. Participants continue their usual medical care while researchers gather data from clinical records. The study will analyze outcomes such as no evidence of disease activity, relapse rates, MRI activity, disability progression or improvement, treatment changes, serious adverse events, and mortality over up to 24 years. Data quality is ensured through validation checks, and privacy is maintained by pseudonymizing information. No extra treatments or visits are required for research purposes, and safety outcomes are monitored from routine data where available.

CONDITIONS

Brief Title

REAL-MS: Observational Database Study of AHSCT and MS Therapies

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here